Estudios de la tuberculosis desde la Sucursal del Cielo

Hipocrates the Aphorisms of Hippocrates: With a Translation Into Latin and English: A. J. Valpy; 1822.

Frith J. History of tuberculosis Part 1 – Pthisis, consumption and the White Plague. Journal of Military and Veterans’ Health. 2014;22(2).

Roguin A. Rene Theophile Hyacinthe Laënnec (1781-1826): The man behind the stethoscope. Clin Med Res. 2006;4(3):230-5.

Chen CC, Chen YN, Liou JM, Wu MS, Consortium TGDaH. From germ theory to germ therapy. Kaohsiung J Med Sci. 2019;35(2):73-82.

Wollman AJ, Nudd R, Hedlund EG, Leake MC. From Animaculum to single molecules: 300 years of the light microscope. Open Biol. 2015;5(4):150019.

Doetsch RN. Benjamin Marten and his “New Theory of Consumptions”. Microbiol Rev. 1978;42(3):521-8.

Koch R. Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882. Rev Infect Dis. 1982;4(6):1270-4.

Bishop PJ, Neumann G. The history of the Ziehl-Neelsen stain. Tubercle. 1970;51(2):196-206.

Kinyoun JJ. A note on uhlenhuths method for sputum examination, for tubercle bacilli. Am J Public Health (N Y). 1915;5(9):867-70.

Darzins E. The bacteriology of tuberculosis. Minneapolis,: University of Minnesota Press; 1958. 488 p. p.

Truant JP, Brett WA, Thomas W. Fluorescence microscopy of tubercle bacilli stained with auramine and rhodamine. Henry Ford Hosp Med Bull. 1962;10:287-96.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;1:CD009593.

Caulfield AJ, Wengenack NL. Diagnosis of active tuberculosis disease: From microscopy to molecular techniques. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2016;4:33-43.

World Health Organization. Global Tuberculosis Report; 2019. Available at: https://www.who.int/tb/publications/global_report/en/.revisado 08- 08, 2020.

Schwabacher H. The pitfalls in the laboratory diagnosis of urinary tuberculosis: A Report of the Address given at the Urological Section of the Royal Society of Medicine. 1937;- 9(- 3):- 275.

Essawy TS, Saeed AM, Fouad NA. Comparative study between using Lowenstein Jensen, Bio-FM media and mycobacteria growth indicator tube (MGIT) system in identification of Mycobacterium tuberculosis. Egyptian Journal of Chest Diseases and Tuberculosis. 2014;63(2):8.

Kudoh S, Kudoh T. A simple technique for culturing tubercle bacilli. Bull World Health Organ. 1974;51(1):71-82.

Youmans AS, Youmans GP. Studies on the metabolism of Mycobacterium tuberculosis. III. The growth of Mycobacterium tuberculosis var. hominis in the presence of various intermediates of the dissimilation of glucose to pyruvic acid. J Bacteriol. 1953;65(1):100-2.

Dubos RJ, Middlebrook G. Media for tubercle bacilli. Am Rev Tuberc. 1947;56(4):334-45.

Middlebrook G, Dubos RJ. The effect of tubercle bacilli on the antigenicity of a synthetic ester of oleic acid. J Immunol. 1947;56(4):301-6.

Sewell DL, Rashad AL, Rourke WJ, Poor SL, McCarthy JA, Pfaller MA. Comparison of the Septi-Chek AFB and BACTEC systems and conventional culture for recovery of mycobacteria. J Clin Microbiol. 1993;31(10):2689-91.

Pfyffer GE, Cieslak C, Welscher HM, Kissling P, Rusch-Gerdes S. Rapid detection of mycobacteria in clinical specimens by using the automated BACTEC 9000 MB system and comparison with radiometric and solidculture systems. J Clin Microbiol. 1997;35(9):2229-34.

Mattei R, Savarino A, Fabbri M, Moneta S, Tortoli E. Use of the BacT/Alert MB mycobacterial blood culture system for detection of mycobacteria in sterile body fluids other than blood. J Clin Microbiol. 2009;47(3):711-4.

Tortoli E, Cichero P, Piersimoni C, Simonetti MT, Gesu G, Nista D. Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol. 1999;37(11):3578-82.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495-505.

Lumb R, Lanser JA, Lim IS. Rapid identification of mycobacteria by the Gen-Probe Accuprobe system. Pathology. 1993;25(3):313-5.

Machado D, Couto I, Viveiros M. Advances in the molecular diagnosis of tuberculosis: From probes to genomes. Infect Genet Evol. 2019;72:93- 112.

Opota O, Zakham F, Mazza-Stalder J, Nicod L, Greub G, Jaton K. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting. J Clin Microbiol. 2019;57(2).

El Khéchine A, Couderc C, Flaudrops C, Raoult D, Drancourt M. Matrixassisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice. PLoS One. 2011;6(9):e24720.

Cao Y, Wang L, Ma P, Fan W, Gu B, Ju S. Accuracy of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria: a systematic review and meta-analysis. Sci Rep. 2018;8(1):4131.

Cao Y, Wang L, Ma P, Fan W, Gu B, Ju S. Accuracy of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria: a systematic review and meta-analysis. Sci Rep. 2018;8(1):4131.

Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults. Cochrane Database Syst Rev. 2016(5):CD011420.

Savolainen L, Kantele A, Sandboge B, Sirén M, Valleala H, Tuompo R, et al. Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV. Clin Vaccine Immunol. 2013;20(9):1479-82.

Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J. 2011;38(6):1398-405.

Lawn SD, Wood R. Point-of-care urine antigen screening tests for tuberculosis and cryptococcosis: potential for mortality reduction in antiretroviral treatment programs in Africa. Clin Infect Dis. 2012;54(5):739-40.

Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a lowcost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2012;12(3):201-9.

World Health Organization. The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV. Policy update. Number of pages: 74. Publication date: 2015. ISBN: 978 92 4 150963 3. WHO/HTM/ TB/2015.25.

Nasreen S, Shokoohi M, Malvankar-Mehta MS. Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(10):e0164034.

Daniel TM. The history of tuberculosis. Respir Med. 2006;100(11):1862- 70.

Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999;159(1):15- 21.

Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012;3(1):2-6.

Vukmanovic-Stejic M, Reed JR, Lacy KE, Rustin MH, Akbar AN. Mantoux Test as a model for a secondary immune response in humans. Immunol Lett. 2006;107(2):93-101.

Burl S, Adetifa UJ, Cox M, Touray E, Whittle H, McShane H, et al. The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. PLoS One. 2010;5(8):e12287.

Lempp JM, Zajdowicz MJ, Hankinson AL, Toney SR, Keep LW, Mancuso JD, et al. Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits. PLoS One. 2017;12(5):e0177752.

Arlehamn CS, Sidney J, Henderson R, Greenbaum JA, James EA, Moutaftsi M, et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol. 2012;188(10):5020- 31.

Nicol MP, Davies MA, Wood K, Hatherill M, Workman L, Hawkridge A, et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics. 2009;123(1):38-43.

Baghaei P, Tabarsi P, Sabour H, Dehghani S, Marjani M, Shamaei M, et al. Detection of Antibodies Against 6, 16 and 38 kDa Antigens of Mycobacterium tuberculosis as a Rapid Test for Diagnosis of Tuberculosis. Tanaffos. 2011;10(4):17-22.

Imaz MS, Schmelling MF, Kaempfer S, Spallek R, Singh M. Serodiagnosis of tuberculosis: specific detection of free and complex-dissociated antibodies anti-mycobacterium tuberculosis recombinant antigens. Braz J Infect Dis. 2008;12(3):234-44.

Steingart KR, Ramsay A, Dowdy DW, Pai M. Serological tests for the diagnosis of active tuberculosis: relevance for India. Indian J Med Res. 2012;135(5):695-702.

Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 2016;13(10):e1002152.

Hauck FR, Neese BH, Panchal AS, El-Amin W. Identification and management of latent tuberculosis infection. Am Fam Physician. 2009;79(10):879-86.

Kahwati LC, Feltner C, Halpern M, Woodell CL, Boland E, Amick HR, et al. Screening for Latent Tuberculosis Infection in Adults: An Evidence Review for the U.S. Preventive Services Task Force. 2016.

Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One. 2009;4(1):e4220.

Cuevas LE. The urgent need for new diagnostics for symptomatic tuberculosis in children. Indian J Pediatr. 2011;78(4):449-55.

Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, Cunningham J, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis. 2006;6(10):664-74.

Group. BDW. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95.

Cambier CJ, Falkow S, Ramakrishnan L. Host evasion and exploitation schemes of Mycobacterium tuberculosis. Cell. 2014;159(7):1497-509.

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.

Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010;375(9729):1920-37.

Bentley-Hibbert SI, Quan X, Newman T, Huygen K, Godfrey HP. Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G. Infect Immun. 1999;67(2):581-8.

Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, et al. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. PLoS One. 2014;9(7):e103811.

Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008;21(2):305-33, table of contents.

Sartain MJ, Slayden RA, Singh KK, Laal S, Belisle JT. Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol Cell Proteomics. 2006;5(11):2102-13.

Fu Y, Yi Z, Wu X, Li J, Xu F. Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol. 2011;49(12):4246-51.

Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, et al. miRNA signatures in sera of patients with active pulmonary tuberculosis. PLoS One. 2013;8(11):e80149.

Harapan H, Fitra F, Ichsan I, Mulyadi M, Miotto P, Hasan NA, et al. The roles of microRNAs on tuberculosis infection: meaning or myth? Tuberculosis (Edinb). 2013;93(6):596-605.

Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet. 2006;368(9540):1012-21.

Achkar JM, Cortes L, Croteau P, Yanofsky C, Mentinova M, Rajotte I, et al. Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals. EBioMedicine. 2015;2(9):1160- 8.

Preez ID, Luies L, Loots DT. Metabolomics biomarkers for tuberculosis diagnostics: current status and future objectives. Biomark Med. 2017;11(2):179-94.

Yorgancioglu A, Akin M, Dereli S, Aktogu S, Ilis Z, Sezgin A. The diagnostic value of tuberculostearic acid in tuberculous pleural effusions. Monaldi Arch Chest Dis. 1996;51(2):108-11.

Traunmuller F, Zeitlinger MA, Stoiser B, Lagler H, Abdel Salam HA, Presterl E, et al. Circulating tuberculostearic acid in tuberculosis patients. Scand J Infect Dis. 2003;35(11-12):790-3. 7

Olivier I, Loots dT. A metabolomics approach to characterise and identify various Mycobacterium species. J Microbiol Methods. 2012;88(3):419- 26.

Lau SK, Lee KC, Curreem SO, Chow WN, To KK, Hung IF, et al. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis. J Clin Microbiol. 2015;53(12):3750-9.

Zhou A, Ni J, Xu Z, Wang Y, Lu S, Sha W, et al. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res. 2013;12(10):4642-9.

Haas CT, Roe JK, Pollara G, Mehta M, Noursadeghi M. Diagnostic ‘omics’ for active tuberculosis. BMC Med. 2016;14:37.

Geyer PE, Kulak NA, Pichler G, Holdt LM, Teupser D, Mann M. Plasma Proteome Profiling to Assess Human Health and Disease. Cell Syst. 2016;2(3):185-95.

Parker CE, Borchers CH. Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays. Mol Oncol. 2014;8(4):840-58.

Mehaffy C, Dobos KM, Nahid P, Kruh-Garcia NA. Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum. Clin Proteomics. 2017;14:21.

___________________________________________________________

Rodríguez JC. Tuberculosis. Revista Médica Clínica Las Condes. 2014; 25(3):547-52.

World Health Organization. Global Tuberculosis Report; 2019. Available at: https://www.who.int/tb/publications/global_report/en/. Revisado 08-08, 2020

Sivigila, Instituto Nacional de Salud, Colombia. 2017.

Boletín Epidemiológico Semanal, Instituto Nacional de Salud, Semana epidemiológica 1. 10 de marzo de 2019.

Samaila M, Oluwole O. Extrapulmonary tuberculosis: fine needle aspiration cytology diagnosis. Nigerian journal of clinical practice. 2011; 14(3):297-9.

Cruz I, Salcedo M. Tuberculosis ganglionar: Experiencia en el Instituto Nacional de Enfermedades Respiratorias. Archivos de Pediatría del Uruguay. 2011; 82(1):18-22.

Handa U, Mundi I, Mohan S. Nodal tuberculosis revisited: a review. The Journal of Infection in Developing Countries. 2011; 6(01):6-12.

GE Transmisibles, E de Micobacterias. Protocolo de vigilancia en salud pública. 2016.

Moreno-Pérez D, Martín A, Gómez N, Baquero-Artigao F, Montaner A, Durán D-P, et al. Diagnóstico de la tuberculosis en la edad pediátrica. Anales de Pediatría. 2010.

Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. European Respiratory Journal. 2012; 40(2):442-7.

Marín D, Aristizábal B. Métodos diagnósticos moleculares en tuberculosis. Medicina UPB. 2012; 32(2).

Perez-Velez C, Marais B. Tuberculosis in children. New England Journal of Medicine. 2012; 367(4):348-61.

Cuevas L. The urgent need for new diagnostics for symptomatic tuberculosis in children. The Indian Journal of Pediatrics. 2011; 78(4):449-55.

Boehme C, Nabeta P, Hillemann D, Nicol M, Shenai S, Krapp F. Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine. 2010; 363(11):1005-15.

Oberhelman RA, Soto-Castellares G, Gilman RH, Castillo ME, Kolevic L, Delpino T, et al. A controlled study of tuberculosis diagnosis in HIVInfected and uninfected children in Peru. PloS one. 2015; 10(4).

Wolf H, Mendez M, Gilman RH, Sheen P, Soto G, Velarde AK, et al. Diagnosis of pediatric pulmonary tuberculosis by stool PCR. The American journal of tropical medicine and hygiene. 2008; 79(6):893– 898.

Oberhelman RA, Soto- Castellares G, Gilman RH, Caviedes L, Castillo ME, Kolevic L, et al. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. The Lancet Infectious diseases. 2010; 10(9):612–620.

Pérez-Porcuna TM, Ascaso C, Ogusku MM, Abellana R, Malheiro A, Quinco P, et al. Evaluation of new strategies for the diagnosis of tuberculosis among pediatric contacts of tuberculosis patients. The Pediatric infectious disease journal. 2012

Portillo-Gómez L, Murillo-Neri MV, Gaitan-Mesa J, Sosa-Iglesias EG. Nested polymerase chain reaction in the diagnosis of cervical tuberculous lymphadenitis in Mexican children. The International Journal of Tuberculosis and Lung Disease. Noviembre de 2008;12(11):1313-9.

Lima JF da C, Montenegro LML, Montenegro R de A, Cabral MML, Lima AS, Abath FGC, et al. Performance of nested PCR in the specific detection of Mycobacterium tuberculosis complex in blood samples of pediatric patients. Jornal Brasileiro de Pneumologia. 2009; 35(7):690-7.

Sieiro TL de A, Aurílio RB, Soares ECC, Chiang SS, Sant´Anna CC. The role of the Xpert MTB/RIF assay among adolescents suspected of pulmonary tuberculosis in Rio de Janeiro, Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 2018; 51(2):234-6.

Montenegro S, Gilman R, Sheen P, Cama R, Caviedes L, Hopper T, et al. Improved Detection of Mycobacterium tuberculosis in Peruvian Children by Use of a Heminested IS6110 Polymerase Chain Reaction Assay. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2003; 36:16-23.

Pallas S, Courey M, Hy C, Killam W, Warren D, Moore B. Análisis de costos del diagnóstico de tuberculosis en Camboya con y sin Xpert ® MTB / RIF para personas que viven con VIH / SIDA y personas con tuberculosis presuntamente resistente a múltiples fármacos. Economía de la salud aplicada y política de salud. 2018; 16(4):537–548.

Nicol MP, Zar HJ. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatric respiratory reviews. 2011; 12(1):16–21.

World Health Organization. Next Generation Xpert MTB/RIF Ultra assay recommended by WHO. 2017.

Alvis-Zakzuk NJ, Carrasquilla M de los Á, Gómez VJ, Robledo J, Alvis- Guzmán NR, Hernández JM. Precisión diagnóstica de tres pruebas moleculares para detectar la tuberculosis multirresistente. Biomédica. 2017; 37(3):397-407.B.

________________________________________________________________

World Health Organization. Global tuberculosis control report 2018. Geneva: WHO; 2019.

Secretaría de Salud Pública Municipal de Cali. Alcaldía de Santiago de Cali: Informe de Vigilancia en Salud Pública de Tuberculosis (evento 813), semana epidemiológicas 1 – 52, AÑO 2018; 2019; p 20.

Instituto Nacional de Salud. Informe de evento: tuberculosis, Colombia, 2018. Consultado: 2020 Jul 14. Disponible en: https://www.ins.gov.co/ buscador-eventos/Informesdeevento/TUBERCULOSIS_2018.pdf

World Health Organization. Estrategia Fin a la TB: objetivos e indicadores. Geneva: WHO; 2016.

Instituto Nacional de Salud. Informe de evento: tuberculosis, Colombia, 2019. Consultado: 2020 Jul 14. Disponible en: https://www.ins.gov.co/ buscador-eventos/Informesdeevento/TUBERCULOSIS%20PE%20 XIII%202019.pdf

Arbeláez CM. Mortalidad evitable por el cuidado sanitario en la ciudad de Cali 1998 a 2006 [Posgrado]. Universidad del Valle; 2007.

Zúñiga HM. Detección de Mycobacterium tuberculosis mediante PCR en tiempo real [Pregrado]. Universidad del Valle; 2008.

Arboleda H, Barreto DK, Domínguez A, Gallego D. Frecuencia de infección latente, medidas de exposición y desarrollo antropométrico en niños contactos de adultos con tuberculosis, Cali Colombia 2005-2008 [Pregrado]. Universidad del Valle; 2009.

Rengifo J, Astudillo M, Pazos A, Bravo LE. Inflamación Granulomatosa Crónica: Métodos de detección de bacilos ácido alcohol resistentes en biopsias embebidas en parafina. Acta biológica colombiana 2010; 15(2): 263-270.

Mueses HF. Factores predictores de la adherencia al tratamiento antituberculoso en 4 municipios del Valle del Cauca, 2004 [Posgrado]. Universidad del Valle; 2009.

Wilches-Luna EC, Hernández NL, Hernández OM, Pérez-Vélez CM. Conocimientos, actitudes, prácticas y educación sobre tuberculosis en estudiantes de una facultad de salud. Revista de Salud Pública. 2016; 18(1): 129-141.

Quintero JA. Análisis espacial de la distribución de casos notificados de TBC años 2005 - 2008 en el área urbana del municipio de Santiago de Cali [Posgrado]. Universidad del Valle; 2010.

Carrillo SL. Prevalencia de sintomáticos respiratorios y factores relacionados a la búsqueda de atención por Tos de más de 15 días en el Valle del Cauca/2010 [Posgrado]. Universidad del Valle; 2010.

Elvira SL, Quiñones FI. Comportamientos de búsqueda de atención en salud en la población mayor de 15 años con diagnóstico de tuberculosis pulmonar en 5 instituciones prestadoras de servicios de salud de la ESE ladera, Cali, Colombia 2008-2009 [Posgrado]. Universidad del Valle; 2010.

Castillo MA, Jaramillo E, Castillo DC. Calidad de vida relacionada con la salud y el desempeño ocupacional en actividades de la vida diaria de usuarios con diagnóstico de tuberculosis pulmonar activa inscritos en el programa de control de tuberculosis de la ciudad de Cali en el periodo febrero - junio de 2010 [Posgrado]. Universidad del Valle; 2011.

Niño VE. Evaluación de IFN-gamma intracelular, proliferación y activación de linfocitos T CD4, TCD8, NK y NKT en pacientes con tuberculosis y sus contactos [Posgrado]. Universidad del Valle; 2011.

Chamorro EM. Factores relacionados con el resultado positivo de una prueba de tuberculina en contactos de pacientes con tuberculosis pulmonar en Cali 2012 [Posgrado]. Universidad del Valle; 2012.

Abouchaar G. Factores asociados al estigma en pacientes en tratamiento de Tuberculosis en la red pública de Santiago de Cali 2002 [Posgrado]. Universidad del Valle; 2012.

Bustamante-Rengifo JA, Sua LF, Astudillo M, Bravo LE. Solitary intracranial tuberculoma mimicking a malignant tumor in a patient without tubercular lesions or a history if disease: a case report. Bosn J Basic Med Sci. 2013; 13(2):129-33. doi: 10.17305/bjbms.2013.2396.

Cruz AC, Martínez S. Análisis de la morbilidad y letalidad de la tuberculosis pulmonar en la ciudad de Santiago de Cali en los períodos 2010-2012 [Pregrado]. Universidad del Valle; 2013.

Espinosa M, Escandón S. Informe de Gestión Consultoría Fortalecer la Estrategia Alto a la Tuberculosis en 46 Municipios del Litoral Pacífico Colombiano, contrato/registro: 2121679 y 2131939 [Internet]. Cali: Universidad del Valle, FENADE. 2013. Disponible en: https:// es.slideshare.net/scaneando/dotstaes-comunitario-una-estrategia-deatencin- para-la-tuberculosis

Wilches EC, Rivera JA, Mosquera R, Loaiza L, Obando L. Rehabilitación pulmonar en tuberculosis multirresistente (TB-MDR): informe de un caso. Colombia Médica. 2009; 40 (4): 442-447.

Daza JE, Cubides AM, Lozada H. Prevalencia de sintomáticos respiratorios y factores relacionados en dos territorios vulnerables de Santiago de Cali. Hacia la Promoción de la Salud. 2016; 21(1), 63-76.

Moreno LA. Diagnóstico molecular de tuberculosis infantil como una herramienta para la salud pública [Posgrado]. Universidad el Valle; 2014.

Evaluación de Captación de Sintomáticos Respiratorios en el Municipio de Cali durante el Periodo 2012-2014 [Posgrado]. Universidad del Valle; 2014.

García DF. Tipificación por minisatélites de aislados clínicos de Mycobacterium tuberculosis en una población en Cali (Colombia) [Pregrado]. Universidad del Valle; 2015.

Salamanca L. Riesgo de transmisión de tuberculosis en relación con las medidas de control administrativas, de medio ambiente y respiratorias en hospitales públicos en Cali [Posgrado]. Universidad del Valle; 2015.

Prevalencia de sintomáticos respiratorios y prevalencia de tuberculosis pulmonar en sintomáticos respiratorios en población mayor de 15 años de Cali, Cartago, Tuluá, Palmira y Buenaventura [Posgrado]. Universidad del Valle; 2010.

García LM. Determinantes sociales estructurales e intermedios relacionados con la mortalidad en personas con diagnóstico de TB pulmonar en Cali 2012 [Posgrado]. Universidad del Valle; 2014.

Somma D, Thomas BE, Karim F, Kemp J, Arias N, Auer C et al. Gender and socio-cultural determinants of TB-related stigma in Bangladesh, India, Malawi and Colombia, Special section on gender and TB. Int J Tuberc Lung Dis 2008; 12 (7): 856-866.

Consorcio Nacional Tuberculosis: investigación básica y aplicada integradas a la salud pública, para mejorar su control 2005-2009. COLCIENCIAS.

Ferro BE, Pérez-Vélez CM, Moreira CA, Hernández EL, Totten SE, Dang- Ta KC, et al. Preliminary evaluation of HSTB medium for susceptibility testing to first and second line antituberculosis agents. Poster abstracts Book 12th Annual Conference International Union against Tuberculosis and Lung Disease-North America Region 2008; 44. San Diego, USA.

Romero IC, Mehaffy C, Burchmore RJ, Dobos-Elder K, Brennan P, Walker J. Identification of promoter-binding proteins of the fbp A and C genes in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2010; 90(1):25-30. doi: 10.1016/j.tube.2009.10.001. Epub 2009 Dec 3.

Rojas CM, Villegas SL, Piñeros HM, Chamorro EM, Durán CE, Hernández, EL, et al. Características clínicas, epidemiológicas y microbiológicas de una cohorte de pacientes con tuberculosis pulmonar en Cali, Colombia. Biomédica 2010; 30(4): 482-491.

Perez-Velez CM, Wilches-Luna EC, Hernández-Sarmiento JM, Casanova-Reynolds AL, Hernández N, Moreno-Ortega SP et al. Preliminary results of a comparative yield study of induced sputum, string test, and gastric aspirate for the microbiological diagnosis of pulmonary tuberculosis in children. American Thoracic Society 2010. In A51, diagnosis of latent and active tuberculosis: A1775-A1775.

Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G, et al. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. JAMA 2011; 305(14): 1415- 1423.

Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D. Multidrugresistant Mycobacterium tuberculosis, southwestern Colombia. Emerg Infect Dis 2011; 17(7): 1259.

Nieto LM, Ferro BE, Villegas SL, Mehaffy C, Forero L, Moreira C, et al. Characterization of extensively drug resistant tuberculosis (XDRTB) cases from Valle del Cauca, Colombia. J Clin Microbiol 2012 Dec; 50(12): 4185-7.

Ferro BE, García PK, Nieto LM, van Soolingen D. Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia. J Clin Microbiol. 2013 Jul; 51(7): 2220-4.

de Beer JL, Ködmön C, van Ingen J, Supply P, van Soolingen D; Global Network for Molecular Surveillance of Tuberculosis 2010. Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis 2014 May; 18 (5): 594-600.

Realpe T, Correa N, Rozo JC, Ferro BE, Gomez V, Zapata E, et al. Population structure among Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Colombia. PLoS One 2014 Apr 18; 9(4):e93848. doi: 10.1371/journal.pone.0093848.

Villegas SL, Ferro BE, Rojas CM, Perez-Velez CM. Assessment of children exposed to adult pulmonary tuberculosis in Cali, Colombia. Paediatr Int Child Health. 2014 Aug; 34(3): 170-7.

Rueda J, Realpe T, Mejia GI, Zapata E, Rozo JC, Ferro BE et al. Genotypic analysis of genes associated with independent and cross-resistance to Isoniazid and Ethionamide in M. tuberculosis clinical isolates. Antimicrob Agents Chemother 2015 Dec; 59 (12): 7805-10.

Genómica comparativa de cepas de Mycobacterium tuberculosis “Beijinglike” un patógeno emergente en Colombia. 2013-2016. COLCIENCIAS.

Cubides ÁM, Zapata H, Ortiz ME, López K, Cifuentes C, Taylor CV, Varela A. Evaluación de la estrategia DOTS en Santiago de Cali. Revista Medicina y Salud FUSM 2013; 1(1).

Esguerra M. Abdomen agudo por Tuberculosis Peritoneal en el Hospital San Juan de Dios en el periodo mayo de 2007 a diciembre de 2007 [Pregrado]. Universidad Santiago de Cali; 2008.

Obeso D, Vargas B, Hurtado AY, Angulo OL. Caracterización de los pacientes inscritos al programa de tuberculosis en la ciudad de Cali 2007 [Pregrado]. Universidad Santiago de Cali; 2008.

Daenz CA. Prevalencia institucional de sintomáticos respiratorios y características clínicas relacionadas red de salud ladera, Santiago de Cali, 2008 [Pregrado]. Universidad Santiago de Cali; 2008.

García C, Ramos AA, Gallego A, Ramírez CM, Soto JF. Caracterización de tuberculosis ganglionar en adulto joven. Reporte de un caso [Pregrado]. Universidad Santiago de Cali; 2013.

Gómez M. Factores asociados a la no adherencia al tratamiento en pacientes con Tuberculosis Pulmonar del Programa del Centro de Salud Obrero, 2014 [Pregrado]. Universidad Santiago de Cali; 2014.

Luna E, Torres S, Patiño J, Amú JV. Linfadenitis tuberculosa mediastinal sin compromiso pulmonar en un paciente estudiante de medicina, inmunocompetente [Pregrado]. Universidad Santiago de Cali; 2014.

Bertin IE. Prevalencia de Sintomáticos Respiratorios como Factor de Riesgo para Tuberculosis Pulmonar, en Estudiantes de Medicina de Quinto y Sexto Año de la Universidad Santiago de Cali, en el Primer Semestre de 2015 [Pregrado]. Universidad Santiago de Cali; 2015.

Casanova AE. Factores de Riesgo de la Tuberculosis Pulmonar en Población Infantil en una E.S.E de Cali, 2008 al 2013 [Pregrado]. Universidad Santiago de Cali; 2015.

Cifuentes A. Valores Espirometricos y Capacidad Aeróbica en Pacientes con Secuelas de Tuberculosis Pulmonar que Asistieron a un Centro de Salud de la Ciudad de Cali en el año 2015 [Pregrado]. Universidad Santiago de Cali; 2015.

González LM. Factores relacionados con la adherencia o no al tratamiento de la TB en pacientes con diagnostico confirmado de TB que asisten a una IPS Publica de Baja Complejidad en el año 2014. Universidad Santiago de Cali; 2015.

Muriel L. Factores relacionados con la adherencia al tratamiento en pacientes con Tuberculosis en el Centro de Salud Luis H. Garcés y Centro de Salud de Obrero [Posgrado]. Universidad Santiago de Cali; 2015.

Tabares A. Prevalencia de sintomáticos respiratorios como factor de riesgo para tuberculosis pulmonar en los estudiantes de práctica clínica dela facultad de salud de la Universidad Santiago de Cali [Pregrado]. Universidad Santiago de Cali; 2016.

De Paz D, Potes L, Quiñónez E, Martínez LF, Cepeda M, Guarín N, et al. Resistencia a fármacos antituberculosis en pacientes coinfectados con tuberculosis y virus de la inmunodeficiencia humana, en un hospital de referencia de 2007 a 2010 en Cali (Colombia). Infectio 2012; 16(3):161– 165.

Fernández L, De Paz D, Potes L, Quiñonez E, Cepeda M, Garcia-Goez JF. Tuberculosis in a University Medical Center in Cali, Colombia in 2011: A Descriptive Study. Tuberculosis in Vulnerable and Special Populations (pp. A1667-A1667). American Thoracic Society. 2013.

Fernández L, Pérez S, Velásquez M, García-Goez JF. Characterization of Patients with Multi-Drug Resistant Tuberculosis with Surgical Management in a Fourth Level Institution in Cali, Colombia. Tuberculosis in vulnerable and special populations (pp. A1668-A1668). American Thoracic Society. 2013.

Fernández L, Potes LI, De Paz D, Quiñones E, Salguero L, Ortiz D, et al. Pregnancy and Tuberculosis: Results from Tuberculosis Cohorts in a University Hospital Reference in Latin America. In B53. Tuberculosis: Epidemiology (pp. A3211-A3211). American Thoracic Society. 2014.

Rosso F, Pacheco R, Castro A, Prada S, González J, García B, Olaya B, Guarín N, Prieto A, Riascos L, Delgado G. Costo y Efectividad del GenXpert-MTB/RIF ® Para El Diagnóstico de TB Pulmonar en Valle Del Cauca. Fundación Valle del Lili; 2015.

Adams, C. D., Vélez, J. D., & Martínez, L. F. (2015). Xpert® MTB/RIF and very low positive detection in bronchoalveolar lavage: diagnostic concerns. The International Journal of Tuberculosis and Lung Disease, 19(7), 871-873.

Fernández L, Monroy K, Orozco V, Velásquez M. Caracterización de una Cohorte 2010-2015 de Pacientes con Diagnóstico de Tuberculosis llevados a Cirugía Mayor en la Fundación Valle del Lili, un Hospital de Referencia en América Latina. Fundación Valle del Lili; 2015.

Rosso F, Guarín N, Martínez L, García J, Pacheco R, Fernández L. Accuracy of Xpert MTB/RIF for the Diagnosis of Smear-Negative Tuberculosis Using Bronchoalveolar Lavage Fluid in a Hospital Setting. Open Forum Infectious Diseases, Volume 2, Issue suppl_1, December 2015, 585, https://doi.org/10.1093/ofid/ofv133.459

Vélez-Londoño JD, Rosso-Suárez F García-Goez JF, Moncada- Vallejo P, Schweineberg-López J, Posada-Chávez JG, Mesa-Ramírez L, Durán-Rebolledo CE, Caicedo-Rusca LA. Uso de moxifloxacina en el tratamiento de la tuberculosis en pacientes con trasplante renal con contraindicaciones o intolerancia a las rifamicinas. Revista Mexicana de Trasplantes 2015; 4 (Supl. 1). Disponible: https://www.medigraphic. com/pdfs/trasplantes/rmt-2015/rmts151e.pdf

Tuberculosis in recipients of solid-organ transplants during 1995–2015 in Cali, Colombia.

Fernández L, García JF, Monroy K, Muñoz CA. A 40-Year-Old Patient with Autoimmune Hepatitis and Portopulmonary Hypertension With Miliary Tuberculosis. Challenges of Drug Treatment: A Case Report. In B50. TUBERCULOSIS: CASE REPORTS (pp. A3783-A3783). American Thoracic Society. 2016.

Fernandez L, Garcia JF, Monroy K, Muñoz, C. A. Treatment Outcomes Of Tuberculosis Patients: Cohort 2014 In a Private Sector in Cali, Colombia. In C58. Tuberculosis Infection and Disease (pp. A5527-A5527). American Thoracic Society. 2016.

González MI, Urrutia LA, Muñoz DE, Manrique DA. Características de pacientes con tuberculosis en Santiago de Cali, 2012 [Pregrado]. Universidad Libre; 2012.

Franco N, Gaviria JA, Ortega N, Vargas M. Características de los pacientes en tratamiento de tuberculosis en la Red Pública de Santiago de Cali 2011-2012 [Pregrado]. Universidad Libre; 2012.

Castillo LF, López H, Rubio MA. Nivel de conocimientos sobre tuberculosis en pacientes asistentes al programa de control de enfermedad en los puntos de atención de la ESE Ladera en la comuna 20 Santiago de Cali, abril-mayo 2012 [Pregrado]. Universidad Libre; 2013.

Echeverri D, Matta L. Tuberculous pericarditis. Biomédica. 2104; 34(4), 528-534.

López AM. Fallas e inasistencias como predictores tempranos de abandono al tratamiento antituberculoso en una empresa social del estrado de I nivel de complejidad en el municipio de Santiago de Cali [Posgrado]. Universidad Libre; 2015.

Mancilla A. Factores de riesgo y distribución geoespacial asociados a la coinfección TBP/VIH, en pacientes con tuberculosis pulmonar atendidos por el Programa de Tuberculosis de la ciudad de Cali entre 2010 y 2014 [Posgrado]. Universidad Libre; 2015.

Barbosa A, Peña O, Valderrama-Aguirre A, Restrepo H. Factores de Riesgo para Tuberculosis en Trabajadores de Servicios de Urgencias, en dos Niveles de Atención en Salud. Revista Colombiana de Salud Ocupacional. 2015; 4(2), 30-33.

Córdoba CD. Factores relacionados a las recaídas en los pacientes con Tuberculosis Pulmonar en la ciudad de Santiago de Cali en el período 2013-2014 [Posgrado]. Universidad Libre; 2015.

Buriticá PA. Distribución temporo espacial del riesgo de tuberculosis y factores relacionados con conglomerados en Cali 2009 al 2013 [Posgrado]. Universidad Libre; 2015.

Mueges SI. Incidencia, prevalencia y factores asociados a tuberculosis en un centro carcelario de Cali, Colombia 2013-2014 [Posgrado]. Universidad Libre; 2015.

Prada SI, Aguirre AF. Complejidad innecesaria: tratamiento de tuberculosis y descentralización territorial en Colombia. Coyuntura económica: investigación económica y social 2013; 43 (2): 53-79.

Leib S, García JF. CA-125 como biomarcador diagnóstico de tuberculosis [Pregrado]. Universidad Icesi; 2014.

García-Goez JF, Munévar HE, Pacheco R. Tuberculosis en pacientes mayores de 80 años atendidos en una institución de alta complejidad [Pregrado]. Universidad Icesi; 2015.

García JF, Cayla J, Restrepo-Cedeño A, Pacheco R. Clinical characteristics of tuberculosis patients with Diagnosis delay in Cali Colombia

Restrepo-Cedeño A, Pacheco R, Cayla J, García JF. Clinical isolations of Nontuberculous Mycobacteria in Cali, Colombia [Pregrado]. 2015.

Bolaños M. Representaciones sociales sobre pacientes con tuberculosis entre profesionales de salud de Cali. Universidad Icesi; 2016.

Mateus-Solarte JC, Carvajal-Barona R. Factors predictive of adherence to tuberculosis treatment, Valle del Cauca, Colombia. Int J Tuberc Lung Dis 2008; 12(5): 520-526.

Girón SL, Mateus JC. Informe técnico final “Costo-efectividad de dos formas de entrega del Tratamiento Directamente Observado en un área demostrativa de la estrategia DOTS en Colombia” [Internet]. Cali: Fundación FES Social Entidad, Secretaría de Salud Pública Municipal de Cali; 2013 p. 1-14. Disponible en: 27. https://aprenderly.com/doc/1140457/informe-tecnico-final-dotsversion- web

Prevalencia de Sintomáticos Respiratorios y de Tuberculosis en el Valle del Cauca 2008.

Giron SL. Costo-efectividad de dos estrategias para mejorar la adherencia al tratamiento antituberculoso en Cali Colombia [Posgrado]. FES/ Instituto Nacional de Salud Pública de México; 2015.

Caracterización de los pacientes inscritos en el programa de tuberculosis en Santiago de Cali. Fundación Universitaria San Martin; 2008.

Factores asociados al retraso en el diagnóstico de tuberculosis pulmonar - TB y costos familiares en Cali, Colombia. Fundación Universitaria San Martin; 2010.

Lugo A. Incidencia de tuberculosis en la ciudad de Cali durante los años 2009-2010 [Pregrado]. Fundación Universitaria San Martin, 2012.

Arrivillaga, M. Barreras sociales, administrativas y culturales que se presentan en los pacientes con diagnóstico de TB para un manejo integral con éxito en el Tratamiento Acortado. Universidad Javeriana Cali; 2013.

Carvajal-Barona R, Tovar-Cuevas LM, Aristizábal-Grisales JC, Varela- Arévalo MT. Barreras asociadas a la adherencia al tratamiento de tuberculosis en Cali y Buenaventura, Colombia, 2012. Revista Gerencia y Políticas de Salud 2017; 16(32): 68-84.

De la Pava E, Fernández O, Salguero B. Modelación matemática con estructura de edad del riesgo de infección tuberculosa en la ciudad de Cali. Matemáticas: Enseñanza Universitaria. 2008; 16(2), 37-56.

Alviz ER, Mondragón CH. Adherencia a la terapia farmacológica y sus factores determinantes en pacientes con tuberculosis de un centro de salud de Santiago de Cali. Revista Colombiana de Ciencias Químico- Farmacéuticas 2014; 43(1): 104-119.

Rodríguez DA, Verdonck K, Bissell K, Victoria JJ, Khogali M, Marín D, Moreno, E. Monitoring delays in diagnosis of pulmonary tuberculosis in eight cities in Colombia. Revista Panamericana de Salud Pública. 2016; 39, 12-18.

Mejía MF, Tovar I, Gómez A, Bonilla M, Berrio A, Pérez A. Conocimiento y Actitud del Futuro Odontólogo frente a pacientes con Diagnóstico de Tuberculosis (tb). Journal Odontológico Colegial 2009; 2(4).

Red TB Pacífico: Universidad Icesi, CIDEIM, FES, Fundación Valle del Lili, Secretaría Departamental de Salud del Valle. Estrategias de Apoyo para mejorar el acceso al diagnóstico y al tratamiento de tuberculosis en niños en el municipio de Cali [Internet]. Icesi de frente a la tuberculosis. 2013 [citado el 14 de julio de 2020]. Disponible en: https://www.icesi.edu. co/unicesi/todas-las-noticias/1025-icesi-de-frente-a-la-tuberculosis

Castañeda-Hernández DM, Bolívar-Mejía A, Rodríguez-Morales AJ. La investigación científica en tuberculosis: Evaluación Bibliométrica de las contribuciones de la literatura colombiana. Revista Médica de Risaralda. 2013; 19 (1): 4-9.

Ramos J, Masiá M, Padilla S, García-Pachón E, Gutiérrez F. Producción española sobre tuberculosis a través del MEDLINE (1997– 2006). Archivos de Bronconeumología 2009; 45(6):271-278.

_______________________________________________________

World Health Organization. Global Tuberculosis Report; 2019. Available at: https://www.who.int/tb/publications/global_report/en/. revisado 08- 08, 2020

Instituto Nacional de Salud. Informe Evento Tuberculosis, Colombia. 2018.

Instituto Nacional de Salud. Informe Evento Tuberculosis, Periodo epidemiológico XIII Colombia 2019.

Instituto Nacional de Salud. Informe Evento Tuberculosis Farmacorresistente, Periodo epidemiológico XIII Colombia 2019.

Moreira CA, Hernandez HL, Arias NL, Castano MC, Ferro BE, Jaramillos E. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia]. Biomedica : revista del Instituto Nacional de Salud. 2004;24 Supp 1:73-9.

Villegas SL, Ferro BE, Perez-Velez CM, Moreira CA, Forero L, Martinez E, et al. High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public-private initiative. The European respiratory journal. 2012;40(6):1569-72.

O’Brien TF, Stelling JM. WHONET: removing obstacles to the full use of information about antimicrobial resistance. Diagnostic microbiology and infectious disease. 1996;25(4):162-8.

Papaventsis D, Nikolaou S, Karabela S, Ioannidis P, Konstantinidou E, Marinou I, et al. Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009. Euro surveillance :bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2010;15(28).

Instituto Nacional de Salud. Guia para el manejo programatico de pacientes con TB farmacorresistente. 2013.

Foxman B, Riley L. Molecular epidemiology: focus on infection. American journal of epidemiology. 2001;153(12):1135-41.

Sharma A, Grover PS. Application of WHONET for the surveillance of antimicrobial resistance. Indian journal of medical microbiology. 2004;22(2):115-8.

Stelling JM, O’Brien TF. Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis. 1997;24 Suppl 1:S157-68.

Montufar Andrade FE, Aguilar Londoño C, Saldarriaga Acevedo C, Quiroga Echeverri A, Builes Montaño CE, Mesa Navas MA, et al. [Clinical features, risk factors and susceptibility profile of mycobacterial infections documented by culture in a university hospital of high complexity in Medellin (Colombia)]. Rev Chilena Infectol. 2014;31(6):735-42.

_________________________________________________

Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Hostdirected therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018;17(1):35-56.

World Health Organization. Global Tuberculosis Report; 2019. Available at: https://www.who.int/tb/publications/global_report/en/. revisado 08- 08, 2020

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Primers. 2016;2:16076.

Moya EM, Chavez-Baray SM, Martínez O. Micro and Macro Social Work Practice in the Context of Tuberculosis. EHQUIDAD. 2017;8:43-66.

Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, et al. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017;12(1):33.

Chang SH, Cataldo JK. A systematic review of global cultural variations in knowledge, attitudes and health responses to tuberculosis stigma. Int J Tuberc Lung Dis. 2014;18(2):168-73, i-iv.

Colson PW, Couzens GL, Royce RA, Kline T, Chavez-Lindell T, Welbel S, et al. Examining the impact of patient characteristics and symptomatology on knowledge, attitudes, and beliefs among foreignborn tuberculosis cases in the US and Canada. J Immigr Minor Health. 2014;16(1):125-35.

Villar Aguirre M. Factores determinantes de la salud: Importancia de la prevención. Acta Médica Peruana. 2011;28:237-41.

Mponela MJ, Oleribe OO, Abade A, Kwesigabo G. Post exposure prophylaxis following occupational exposure to HIV: a survey of health care workers in Mbeya, Tanzania, 2009-2010. Pan Afr Med J. 2015;21:32.

Lozano JA. Tuberculosis. Patogenia, diagnóstico y tratamiento. Offarm. 2002;21(8):102-10.

Uden L, Barber E, Ford N, Cooke GS. Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-Analysis. Open Forum Infect Dis. 2017;4(3):ofx137.

de Vries G, Sebek MM, Lambregts-van Weezenbeek CS. Healthcare workers with tuberculosis infected during work. Eur Respir J. 2006;28(6):1216-21.

Huaroto L, Espinoza MM. Recomendaciones para el control de la transmisión de la tuberculosis en los hospitales. Revista Peruana de Medicina Experimental y Salud Publica. 2009;26:364-9.

Sosa LE, Njie GJ, Lobato MN, Bamrah Morris S, Buchta W, Casey ML, et al. Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(19):439-43.

Jensen PA, Lambert LA, Iademarco MF, Ridzon R, CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, 2005. MMWR Recomm Rep. 2005;54(RR-17):1-141.

Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F. Tuberculosis among health care workers. Emerg Infect Dis. 2011;17(3):488-94.

Diel R, Niemann S, Nienhaus A. Risk of tuberculosis transmission among healthcare workers. ERJ Open Res. 2018;4(2).

Monguí Riaño J, Villamil Ramírez HC, Maestre Daza LM, Muñoz Sánchez AI. Trabajadores de la salud con diagnóstico de tuberculosis en Bogotá, en el periodo 2009-2011. Medicina y Seguridad del Trabajo. 2013;59:417-25.

Organización Panamericana de la Salud. Lineamientos para la implementación del control de infecciones de tuberculosis en las Américas. 2014.

Instituto Nacional de Salud. Protocolo de Vigilancia en Salud Pública Tuberculosis. 2016. p. 1-42.

Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, et al. Interferon-y release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189(1):77-87.

Juan Carlos Rodríguez D. Tuberculosis. Revista Médica Clínica Las Condes. 2014;25(3):547-52.

Muñoz-Sánchez AI, Castro-Cely Y. Medidas de control de tuberculosis en una institución de salud de Bogotá D.C. Revista Facultad Nacional de Salud Pública. 2016;34:38-47.

Buregyeya E, Nuwaha F, Verver S, Criel B, Colebunders R, Wanyenze R, et al. Implementation of tuberculosis infection control in health facilities in Mukono and Wakiso districts, Uganda. BMC Infect Dis. 2013;13:360.

Situación del control de la tuberculosis en las Américas, (2009).

Rodríguez De la Pinta ML, Maestre Naranjo M, Pérez Zapata A. Prevención y control de la Tuberculosis en trabajadores del ámbito sanitario. Escuela Nacional de Medicina del Trabajo, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. Madrid, España2009.

CDC. Control y prevención de infecciones 2016 [Available from: https:// www.cdc.gov/tb/esp/topic/infectioncontrol/TBhealthCareSettings.htm.

Schmidt BM, Engel ME, Abdullahi L, Ehrlich R. Effectiveness of control measures to prevent occupational tuberculosis infection in health care workers: a systematic review. BMC Public Health. 2018;18(1):661.

Lee JY. Tuberculosis Infection Control in Health-Care Facilities: Environmental Control and Personal Protection. Tuberc Respir Dis (Seoul). 2016;79(4):234-40.

Nasreen S, Shokoohi M, Malvankar-Mehta MS. Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(10):e0164034.

Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J. 1998;59(2):128-32.

Llerena Polo CR, Zabaleta A. Evaluación por el laboratorio de los casos de tuberculosis en profesionales del área de la salud. Acta Médica Colombiana. 2015;39(4):321-6.

Dobler CC, Farah WH, Alsawas M, Mohammed K, Breeher LE, Murad MH, et al. Tuberculin Skin Test Conversions and Occupational Exposure Risk in US Healthcare Workers. Clin Infect Dis. 2018;66(5):706-11.

Fica CA, Cifuentes DM, Ajenjo HMC, Jemenao PMI, Zambrano OA, Febré VN, et al. Tuberculosis en el personal de salud. Revista chilena de infectología. 2008;25:243-55.

Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among healthcare workers in low- and middle-income countries: a systematic review. PLoS Med. 2006;3(12):e494.

Upegui A LD, Orozco V LC. Diseño de un instrumento para medir estigma hacia la tuberculosis. Revista de la Universidad Industrial de Santander Salud. 2014;46:22-34.

Marais BJ, Lonnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013;13(5):436-48.

Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of noncommunicable and infectious diseases in low-- and middle-income countries. Int J Epidemiol. 2013;42(1):221-7.

Glanzmann B, Uren C, de Villiers N, van Coller A, Glashoff RH, Urban M, et al. Primary immunodeficiency diseases in a tuberculosis endemic region: challenges and opportunities. Genes Immun. 2019;20(6):447-54.

Boisson-Dupuis S, Bustamante J, El-Baghdadi J, Camcioglu Y, Parvaneh N, El Azbaoui S, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015;264(1):103- 20.

______________________________________________________________

Hospital Mario Correa Rengifo. Sobre el hospital. [27 marzo 2017; 31 de agosto 2019] https://www.hospitalmariocorrea.org/index.php

Jiang H., Zhang S., Ding Y., Li Y., Zhang T., Liu W., Ma X. Development and validation of college students’ tuberculosis knowledge, attitudes and practices questionnaire (CS-TBKAPQ). BMC Public Health, 2017; 17, 949. http://doi.org/10.1186/s12889-017-4960-x

Xu, Z., Xiao, T., Li, Y., Yang, K., Tang, Y., & Bai, L. (2017). Reasons for Non-Enrollment in Treatment among Multi-Drug Resistant Tuberculosis Patients in Hunan Province, China. PLoS ONE, 12(1), e0170718. http:// doi.org/10.1371/journal.pone.0170718

Skinner D., & Claassens M. It’s complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infectious Diseases, 2016; 16, 712. http://doi.org/10.1186/ s12879-016-2054-5

Blackmore S. Conversations on consciousness. New York: Oxford; 2006.

Damasio A. Y el cerebro creó al hombre. Barcelona: Destino; 2017.

Araujo HF, Kaplan J, Damasio H, Damasio A. Neural correlates of different self domains. Brain Behav. 2015 [citado 30 ago 2019]; 21;5(12):e00409. doi: 10.1002/brb3.409.

Fuster JM. Cerebro y libertad. Barcelona: Ariel; 2014.

Bartra R. Cerebro y libertad. México: Fondo de Cultura Económica; 2013.

Khemlani SS, Byrne RMJ, Johnson-Laird PN. Facts and Possibilities: A Model-Based Theory of Sentential Reasoning. Cogn Sci. 2018 [citado 30 ago 2019] doi: 10.1111/cogs.12634.

Organización Mundial de la Salud. Día mundial de la tuberculosis. Disponible en https://www.who.int/es/news-room/events/ detail/2019/03/24/default-calendar/world-tb-day-2019

Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008; 8:45. Published 2008 Jul 10. doi:10.1186/1471-2288-8-45

Haefner D, Kirscht P. Motivational and Behavioral Effects of Modifying Health Belief. Pub Health Report 1970 [citado 30 ago 2019].Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2031729/pdf/ pubhealthreporig01054-0012.pdf

Li Z. T., Yang S. S., Zhang X. X., Fisher E. B., Tian B. C., & Sun X. Y. Complex relation among Health Belief Model components in TB prevention and care. Pub Health, 2015 129(7), 907–915. https://doi.org/10.1016/j. puhe.2015.04.008

Tola, H. H., Karimi, M., & Yekaninejad, M. S. Effects of sociodemographic characteristics and patients’ health beliefs on tuberculosis treatment adherence in Ethiopia: a structural equation modelling approach. Infectious Diseases of Poverty, 2017 6, 167. http://doi.org/10.1186/s40249-017- 0380-5

Mirassou, C. S. Health system and aboriginal communities in the province of Formosa, Argentina. Medicina, 2013 73(5), 453–456.

Hailu TH, Shojaeizadehl D, Tol1 A, Garmaroudi Gh, Yekaninejad MS, Kebede A. Psychological and Educational Intervention To Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial. PLOS ONE. 2016; 11(5):e0155147. doi:10.1371/journal.pone.0155147

Fried J., Harris B., Eyles J., & Moshabela M. Acceptable Care? Illness Constructions, Healthworlds, and Accessible Chronic Treatment in South Africa. Qualitative Health Research, 2015; 25(5), 622–635. http://doi. org/10.1177/1049732315575315

Olive L.; Tamayo Pérez R. Temas de ética y epistemología de la ciencia. Diálogos entre un filósofo y un científico. México: Fondo de Cultura Económica; 2011.

Salcedo Gutiérrez H. Epistemología o filosofar sobre la ciencia. Medellín: Ediciones Uniaula; 2012.

Mabunda J. T., Khoza L. B., Van den Borne H. B., & Lebese R. T. Needs assessment for adapting TB directly observed treatment intervention programme in Limpopo Province, South Africa: A community-based participatory research approach. African Journal of Primary Health Care & Family Medicine, 2016; 8(2), 981. http://doi.org/10.4102/phcfm. v8i2.981

Tola H. H., Garmaroudi G., Shojaeizadeh D., Tol, A., Yekaninejad M. S., Ejeta L. T., Kassa D. (2017). The Effect of Psychosocial Factors and Patients’ Perception of Tuberculosis Treatment Non-Adherence in Addis Ababa, Ethiopia. Ethiopian Journal of Health Sciences, 27(5), 447–458.

Sullivan B. J., Esmaili B. E., & Cunningham C. K. Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youth. Global Health Action, 2017; 10(1), 1290317. http://doi.org/10.1080/16549716.2017.1290317

Magee M. J., Darchia L., Kipiani M., Chakhaia T., Kempker R. R., Tukvadze N., Blumberg, H. M. Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 2017; 21(9), 1049–1055. http://doi.org/10.5588/ ijtld.17.0023

Zhu Y., Wu J., Feng X., Chen H., Lu, H., Chen L., Rui C. Patient characteristics and perceived health status of individuals with HIV and tuberculosis coinfection in Guangxi, China. Medicine, 2017; 96(14), e6475. http://doi.org/10.1097/MD.0000000000006475

Hossain M. S., Ahmed F., Fatema-Tuj-Johora & Andersson K. A Belief Rule Based Expert System to Assess Tuberculosis under Uncertainty. Journal of Medical Systems, 2017; 41(3), 43. http://doi.org/10.1007/s10916-017- 0685-8

Diefenbach-Elstob T., Plummer D., Dowi R., Wamagi S., Gula B., Siwaeya K., Warner, J. The social determinants of tuberculosis treatment adherence in a remote region of Papua New Guinea. BMC Public Health, 2017; 17, 70. http://doi.org/10.1186/s12889-016-3935-7

Keikelame M. J., & Swartz L. “It is always HIV/AIDS and TB”: Home-based carers’ perspectives on epilepsy in Cape Town, South Africa. International Journal of Qualitative Studies on Health and Well- Being, 2016; 11, 10.3402/qhw.v11.30213. http://doi.org/10.3402/qhw. v11.30213

Tola H. H., Shojaeizadeh D., Tol, A., Garmaroudi G., Yekaninejad M. S., Kebede A., Klinkenberg E. Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial. PLoS ONE, 2016;

(5), e0155147. http://doi.org/10.1371/journal.pone.0155147

Chida N., Ansari Z., Hussain H., Jaswal M., Symes S., Khan A. J., & Mohammed S. Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study. PLoS ONE, 2015; 10(11), e0142384. http://doi. org/10.1371/journal.pone.0142384

Chizimba R., Christofides N., Chirwa T., Singini I., Ozumba C., Sikwese S., Nyasulu, P. The Association between Multiple Sources of Information and Risk Perceptions of Tuberculosis, Ntcheu District, Malawi. PLoS ONE, 2015; 10(4), e0122998. http://doi.org/10.1371/ journal.pone.0122998

Okwera A., Mafigiri D. K., Guwatudde D., Whalen C., & Joloba M. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis. African Health Sciences, 2015;15(1), 49–57. http://doi.org/10.4314/ahs.v15i1.7

Mirtskhulava V., Whitaker J. A., Kipiani M., Harris D. A., Tabagari N., Owen-Smith A. A., Blumberg H. M. Determinants of Tuberculosis Infection Control Related Behaviors among Healthcare Workers in the Country of Georgia. Infection Control and Hospital Epidemiology, 2015; 36(5), 522–528. http://doi.org/10.1017/ice.2015.5

Viney K. A., Johnson P., Tagaro M., Fanai S., Linh N. N., Kelly P., Sleigh A. Tuberculosis patients’ knowledge and beliefs about tuberculosis: a mixed methods study from the Pacific Island nation of Vanuatu. BMC Public Health, 2014; 14, 467. http://doi.org/10.1186/1471-2458-14-467

O’Donnell M. R., Wolf A., Werner L., Horsburgh C. R., & Padayatchi N. Adherence in the treatment of patients with extensively drugresistant tuberculosis and HIV in South Africa: A prospective cohort study. Journal of Acquired Immune Deficiency Syndromes (1999), 2014; 67(1), 22–29. http://doi.org/10.1097/QAI.0000000000000221

Addisu Y., Birhanu Z., Tilahun D., & Assefa T. Predictors of Treatment Seeking Intention among People with Cough in East Wollega, Ethiopia Based on the Theory of Planned Behavior: A Community Based Cross- Sectional Study. Ethiopian Journal of Health Sciences, 2014;24(2), 131– 138.

Makanjuola T., Taddese H. B., & Booth A. Factors Associated with Adherence to Treatment with Isoniazid for the Prevention of Tuberculosis amongst People Living with HIV/AIDS: A Systematic Review of Qualitative Data. PLoS ONE, 2014; 9(2), e87166. http://doi. org/10.1371/journal.pone.0087166

Louwagie G. M., & Ayo-Yusuf O. A. Tobacco use patterns in tuberculosis patients with high rates of human immunodeficiency virus co-infection in South Africa. BMC Public Health, 2013; 13, 1031. http://doi. org/10.1186/1471-2458-13-1031

Onifade D. A., Bayer A. M., Montoya R., Haro M., Alva J., Franco J., Evans C. A. Gender-related factors influencing tuberculosis control in shantytowns: a qualitative study. BMC Public Health, 2010; 10, 381. http://doi.org/10.1186/1471-2458-10-381

Bishnu B., Bhaduri S., Kumar A. M. V., Click E. S., Chadha V. K., Satyanarayana S., Dewan P. What Are the Reasons for Poor Uptake of HIV Testing among Patients with TB in an Eastern India District? PLoS ONE, 2013; 8(3), e55229. http://doi.org/10.1371/journal.pone.0055229

Colson P. W., Couzens G. L., Royce R. A., Kline T., Chavez-Lindell T., Welbel S., Hirsch-Moverman Y. Examining the Impact of Patient Characteristics and Symptomatology on Knowledge, Attitudes, and Beliefs Among Foreign-born Tuberculosis Cases in the US and Canada. Journal of Immigrant and Minority Health, 2014; 16(1), 125– 135. http://doi.org/10.1007/s10903-013-9787-7

Hambolu D., Freeman J., & Taddese H. B. Predictors of Bovine TB Risk Behaviour amongst Meat Handlers in Nigeria: A Cross-Sectional Study Guided by the Health Belief Model. PLoS ONE, 2013; 8(2), e56091. http://doi.org/10.1371/journal.pone.0056091

Uwimana J., Zarowsky C., Hausler H., & Jackson D. (2012). Engagement of non-government organisations and community care workers in collaborative TB/HIV activities including prevention of mother to child transmission in South Africa: Opportunities and challenges. BMC Health Services Research, 12, 233. http://doi.org/10.1186/1472-6963- 12-233

Ngangro N. N., Ngarhounoum D., Ngangro M. N., Rangar N., Siriwardana M. G., des Fontaines V. H., & Chauvin P. Pulmonary tuberculosis diagnostic delays in Chad: a multicenter, hospital-based survey in Ndjamena and Moundou. BMC Public Health, 2012; 12, 513. http://doi.org/10.1186/1471-2458-12-513

Woith W. M., Volchenkov G., & Larson J. L. Barriers and Facilitators Affecting Tuberculosis Infection Control Practices of Russian Health Care Workers. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease, 2012; 16(8), 1092–1096. http://doi. org/10.5588/ijtld.10.0779

Vukovic D. S., & Nagorni-Obradovic L. M. Knowledge and awareness of tuberculosis among Roma population in Belgrade: a qualitative study. BMC Infectious Diseases, 2011; 11, 284. http://doi. org/10.1186/1471-2334-11-284

Kipp A. M., Pungrassami P., Nilmanat K., Sengupta S., Poole C., Strauss R. P., Van Rie A. Socio-demographic and AIDS-related factors associated with tuberculosis stigma in southern Thailand: a quantitative, cross-sectional study of stigma among patients with TB and healthy community members. BMC Public Health, 2011; 11, 675. http://doi. org/10.1186/1471-2458-11-675

Gebremariam M. K., Bjune G. A., & Frich J. C. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health, 2010; 10, 651. http:// doi.org/10.1186/1471-2458-10-651

Haasnoot P. J., Boeting T. E., Kuney M. O., & van Roosmalen J. Knowledge, Attitudes, and Practice of Tuberculosis among Maasai in Simanjiro District, Tanzania. The American Journal of Tropical Medicine and Hygiene, 2010; 83(4), 902–905. http://doi.org/10.4269/ ajtmh.2010.10-0061

Verhagen L. M., Kapinga R., & van Rosmalen-Nooijens K. A. W. L. Factors underlying diagnostic delay in tuberculosis patients in a rural area in Tanzania: a qualitative approach. Infection, 2010; 38(6), 433–446. http://doi.org/10.1007/s15010-010-0051-y

Nkulu F. K., Hurtig A.-K., Ahlm C., & Krantz I. Screening migrants for tuberculosis - a missed opportunity for improving knowledge and attitudes in high-risk groups: A cross-sectional study of Swedishlanguage students in Umea, Sweden. BMC Public Health, 2010; 10, 349. http://doi.org/10.1186/1471-2458-10-349

Legesse M., Ameni G., Mamo G., Medhin G., Shawel D., Bjune G., & Abebe F. Knowledge and perception of pulmonary tuberculosis in pastoral communities in the middle and Lower Awash Valley of Afar region, Ethiopia. BMC Public Health, 2010; 10, 187. http://doi. org/10.1186/1471-2458-10-187

Colson P. W., Franks J., Sondengam R., Hirsch-Moverman Y., & El-Sadr W. Tuberculosis Knowledge, Attitudes, and Beliefs in Foreign-born and USborn Patients with Latent Tuberculosis Infection. Journal of Immigrant and Minority Health / Center for Minority Public Health, 2010; 12(6), 859–866. http://doi.org/10.1007/s10903-010-9338-4

Ford C. M., Bayer A. M., Gilman R. H., Onifade D., Acosta C., Cabrera L., Evans C. A. Factors Associated with Delayed Tuberculosis Test-seeking Behavior in the Peruvian Amazon. The American Journal of Tropical Medicine and Hygiene, 2009; 81(6), 1097–1102. http://doi.org/10.4269/ajtmh.2009.08-0627

_____________________________________